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Abstract
Background: Ethiopia is one of the high tuberculosis (TB) burden countries. An
analysis of trends and differentials in case notifications and treatment outcomes of
TB may help improve our understanding of the performance of TB control services.
Methods: A retrospective trend analysis of TB cases was conducted in the Sidama
Zone in southern Ethiopia. We registered all TB cases diagnosed and treated
during 2003–2012 from all health facilities in the Sidama Zone, and analysed trends
of TB case notification rates and treatment outcomes.
Results: The smear positive (PTB+) case notification rate (CNR) increased from 55
(95% CI 52.5–58.4) to 111 (95% CI 107.4–114.4) per 105 people. The CNRs of
PTB+ in people older than 45 years increased by fourfold, while the mortality of
cases during treatment declined from 11% to 3% for smear negative (PTB-) (X2trend,
P,0.001) and from 5% to 2% for PTB+ (X2trend, P,0.001). The treatment success
was higher in rural areas (AOR 1.11; CI 95%: 1.03–1.2), less for PTB- (AOR 0.86;
CI 95%: 0.80–0.92) and higher for extra-pulmonary TB (AOR 1.10; CI 95%: 1.02–
1.19) compared to PTB+. A higher lost-to-follow up was observed in men (AOR
1.15; CI 95%: 1.06–1.24) and among PTB- cases (AOR 1.14; CI 95%: 1.03–1.25).
More deaths occurred in PTB-cases (AOR 1.65; 95% CI: 1.44–1.90) and among
cases older than 65 years (AOR 3.86; CI 95%: 2.94–5.10). Lastly, retreatment
cases had a higher mortality than new cases (6% vs 3%).
Conclusion: Over the past decade TB CNRs and treatment outcomes improved,
whereas the disparities of disease burden by gender and place of residence
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reduced and mortality declined. Strategies should be devised to address higher risk
groups for poor treatment outcomes.
Introduction
Tuberculosis (TB) is a major public health problem in the world that affects
approximately nine million people, causing deaths in approximately 1.3 million
[1], with most of the cases and deaths being in sub-Saharan Africa. TB prevention
and control relies on the Directly Observed Treatment, Short-term (DOTS)
strategy, which focuses on case notification and successful treatment as a measure
of its performance [1]. TB differentially affects different segments of the
community. Some studies report a higher male to female ratio in TB case
notification and lower case fatality rates in men [2–5]. Access to treatment, poor
socioeconomic status [6, 7], health service access and use, delays in seeking care
and diagnosis [8] and poor knowledge about the disease [9] all contribute to
discrepancies in case notifications. A change in the occurrence of the disease by
age structure, reducing the proportion of the disease by gender and urban-rural
settings and trends of treatment results are important indicators to assess the
effectiveness of TB control programmes [1, 10, 11].
Ethiopia is one of the high TB burden countries due to the related sickness and
death [1, 12] undergoing an accelerated decentralization of DOTS, which
improved case notification rate and treatment outcomes [13, 14]. Unfortunately,
the case detection rate of smear-positive TB (PTB+) using passive finding which
misses the less advantaged in the community [15], is below the global target of
70% [1, 13]. In such settings, an active case finding (ACF) could be useful to
improve early case finding and treatment at a reasonable cost in resource-
constrained settings [15–18]. TB case detection and treatment results vary
between different regions of Ethiopia [13], which could be influenced by reports
based on basic management units (BMU) regardless of their place of residence. In
real life, people seek diagnosis and treatment wherever the services are accessible,
available and preferred. BMU-based data aggregation includes cases from different
administrative areas, and not only from the institutional catchment population.
This may result in both an over- and underestimation of CNR to the true
population and treatment outcomes for the defined administrative areas.
An analysis of trends and differentials in case notifications and treatment
outcomes by place of residence, gender and age distribution may help improve
our understanding of the performance of DOTS services and true CNR. Previous
reports have focused on trends in TB case detection and treatment outcome by
socio-demographic factors and treatment sites [14, 19, 20]. Nevertheless, these
studies lack a further analysis based on the true address of cases, which could
provide useful evidence for disease control programs for informed decision
making. Therefore, the objective of this study is to assess the trends of TB case
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notification and treatment outcome based on the patient’s address over a period
of 10 years in the Sidama Zone in southern Ethiopia.
Methods
Study Area and Setting
This study was conducted in the Sidama Zone (the study area) in southern
Ethiopia, which is one of the most densely populated areas in Ethiopia, with a
population of over 3.4 million [21, 22]. Ninety-two percent of the population lives
in rural areas, and agriculture is the major livelihood of the community.
Administratively, the Sidama Zone is divided into 19 woredas (districts) and two
towns. Additionally, there are 524 rural and 39 urban kebeles (the lowest
administrative units for approximately 5,000 people or 1,000 households on
average).
In recent years, there has been a substantial expansion of primary health-care
services in the Zone, mostly in relation to public institutions. The public sector
runs two hospitals, 102 health centers, seven non-governmental organization
(NGO) clinics and 519 health posts, though private facilities were not engaged in
TB care during the study period. In 2003, Ethiopia launched the health extension
program, a community-based initiative to improve access to basic primary health-
care services including TB, primarily focusing on households [23]. Each health
post is staffed by two female health extension workers (HEWs) from the local
communities, who have been trained for one year, receive salaries from the
government and provide promotive, preventive and basic curative health services.
DOTS is decentralized and the DOTS providing health facilities in the study
area increased from 65 in 2003 to 114 in 2012. TB and HIV collaborative activities
such as HIV screening and treatment have also been carried out, and 95% of
districts in the study area had at least one ART center in 2012. Health facilities
(health-care services) that provide anti-retroviral treatment increased from one in
2003 to 20 in 2012 [24]. Moreover, in October 2011, the zonal health department
started a community-based intervention focusing on active case finding [15] to
help improve TB case finding and treatment results.
TB Diagnosis and Treatment
We used the National TB control guidelines of Ethiopia for the diagnosis and
treatment of TB cases, for case definition and treatment outcomes [25]. Health
posts render health education, identify suspects, refer patients to health centers
and support treatment through HEWs. Health centers conduct sputum
microscopy, treatment and the referral of smear-negative and extra pulmonary
cases to hospitals for further management, while hospitals provide diagnosis,
treatment and in patient care services [23, 25].
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Case Definition
Smear-positive pulmonary TB (PTB+) is diagnosed with at least two positive
initial sputum smears for Acid Fast Bacilli (AFB) by direct microscopy, or one
positive smear for AFB by direct microscopy and culture positive or one positive
smear for AFB by direct microscopy and radiographic abnormalities consistent
with active TB as determined by a clinician. The laboratory keeps all positive and
negative slides for external quality assurance. Quality assurance is performed
regularly at the regional laboratory, and feedback is given to a reporting health
facility. A previous study reported a high specificity and good agreement of
sputum microscopy between peripheral and reference laboratories [26].
Smear-negative TB (PTB-) is diagnosed when the patient is presented with
symptoms suggestive of TB, has at least three initial smear examinations negative
for AFB, no response to antibiotics, repeat smear-negative and radiological
abnormalities consistent with pulmonary TB, as well as a clinician’s decision.
Extra pulmonary TB (EPTB) is diagnosed by one culture-positive specimen
from an extra pulmonary site or histo-pathological evidence from a biopsy, which
is based on strong clinical evidence consistent with active EPTB by a clinician’s
decision. However, most health facilities diagnose the disease based on a
clinician’s decision because there are inadequate laboratory facilities for sputum
culture or histopathology.
A short course treatment regimen is given for two phases with first line fixed
combination therapy [25]. The intensive phase treatment lasts for two months
with Ethambutol (E), Isoniazid (H), Rifampicin (R) and Pyrazinamide (Z)
followed by a continuous six-month phase with Ethambutol and Isoniazid. Since
2011, the continuation phase has lasted for four months, and uses Isoniazid and
Rifampicin.
Data Collection
The study was conducted from August 2012 to February 2013, and data were
collected from all health facilities providing DOTS services from 2003 to 2012. We
collected TB unit registers from all health facilities in the districts in the year of
treatment.
The variables included were: address of the patient, name of the health facility,
age, sex, smear result, TB category, TB classification, intensive phase drug, year of
treatment, date of treatment started, last date of treatment and treatment
outcome. The treatment results included: treatment completed, cured, defaulted
(lost-to-follow up), died, transferred out and unknown [1, 25]. The address of
patients consisted of the actual district and kebele of the patient at the time of
diagnosis, and we obtained the code for each district and kebele from the Central
Statistical Agency (CSA) of Ethiopia, and linked them to each case in the TB
registers.
The data were entered using Microsoft Access by university graduates with
experience in data management. They were trained for four days with regard to
the formats, variables of interest and data collection, including practical sessions
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by the principal investigator (PI) and experts from the Sidama Zone Department
of Health. Data were double-entered and cross-checked by the PI and experts
from the Zone for the number of cases by year, facilities and districts, in addition
to the correctness and consistency of the information.
We supervised the data entry for completeness and consistency on a regular
basis. In the study area, TB cases are reported by the BMU, irrespective of the
patient address. The BMUs are health facilities or institutions that compile and
report TB cases registered for treatment to higher administrative levels. Thus,
patients coming from neighboring districts or regions are reported as the cases
from the reporting BMU, which forms the basis for the computation of the case
notification and treatment outcomes. We linked the data from cases registered in
districts where the health facility is located, though from neighboring- or other
districts within the study area to their actual districts and kebeles, using CSA
codes to identify the under- or over reporting of case notifications (Table 1). We
also visited neighboring health facilities located outside the study area, checked for
cases from the study area that were diagnosed and treated at health facilities in the
neighboring areas and included them in the study if they were from the study area.
Cases from neighboring region or zones diagnosed and treated in the study area
were excluded from analysis, while transferred out- and transferred in cases were
checked and correctly linked to their treatment outcomes. Addresses with similar
names but from different locations were linked to their correct CSA codes to
prevent duplication or underreporting.
To ensure the quality of the data, we checked the consistency and correctness of
the entered information with the information in the TB registries. All TB unit
registries were made available until the preliminary analysis, and during the
exploratory analysis we looked for errors and corrected them from the registries.
To help ensure the completeness and accuracy of the data, the number of cases
and patient information entered in each year and health facility were checked page
by page and by the year of treatment with the information in the TB registry.
Personal identifiers of TB cases were coded to maintain the confidentiality of the
patient information prior to analysis, and all medical records (TB unit registries)
were kept in a secure place (patient records or information was anonymized and
de-identified prior to analysis).
Statistical Analysis
Descriptive statistics of trends of case notification and treatment outcomes over
the past 10 years were performed for PTB+, PTB- and ETB cases. We obtained
each year’s population data for the study area from CSA [22], computed case
notification rates using the population for different years as a denominator and
notified cases as a numerator. We computed the difference between cases reported
by health facilities and corresponding districts, the BMU, after linking cases to the
correct address in order to acquire actual case notification rates of the study area
and to find any under- or over reporting within the districts. We analyzed trends
of case notification by age, gender, urban and rural residence, and looked for the
TB Case Notification and Treatment Outcomes in Sidama
PLOS ONE | DOI:10.1371/journal.pone.0114225 December 2, 2014 5 / 18
evidence of age shift and trends in case notification, as well as any disparity in the
trends of case notification.
Univariate and bivariate analyses were carried out to investigate the difference
and association between independent and outcome variables. A logistic regression
analysis was used to identify factors associated with treatment success, loss-to-
follow up and mortality during treatment and control for confounding. The data
were exported from Microsoft Access to SPSS version 19. We used SPSS version
19 and EpiInfo 7 for the data analysis, and P,0.05 was considered statistically
significant.
Table 1. Differences in cases notified after linking TB cases to their correct address in the Sidama Zone, 2003–2012.
Name of the district
Cases reported by
BMU
Corrected to true
address
From other districts
N (%)*
To other districts N
(%) ** +/2 Difference N (%) ***
Aleta chuko 2,253 2,663 501 (19) 91 (4) 2 410 (18)
Aleta wondo 1,803 2,623 1,456 (56) 636 (35) 2 820 (45)
Aleta wondo town 1,999 885 85 (10) 1199 (60) + 1114 (56)
Arbegona 650 721 108 (15) 37 (6) 2 71(11)
Aroresa 1,303 1,374 183 (13) 112 (9) 2 71 (5)
Bensa 2,933 2724 102 (4) 311 (11) + 209 (7)
Bona 953 1,004 213 (21) 162 (17) 2 51(5)
Boricha 4,583 3,624 52 (1) 1,011 (22) + 959 (21)
Bursa 638 978 368 (38) 28 (4) 2 340 (53)
Chire 772 954 211 (22) 29 (4) 2 182 (24)
Dale 3,446 3,707 1,024 (28) 763 (22) 2 261 (8)
Dara 1,404 1,345 141 (10) 200 (14) + 59 (4)
Gorche 451 552 104 (19) 3 (1) 2 101 (22)
Hawassa zuriya 1,036 1,642 636 (39) 30 (3) 2 606 (58)
Hula 2,593 1,739 22 (1) 876 (34) + 854 (33)
Loka Abaya 697 1,035 368 (36) 30 (4) 2 338 (48)
Malga 957 926 26 (3) 57 (6) + 31 (3)
Shebedino 2,568 2,937 510 (17) 141 (5) 2 369 (14)
Wondo Genet 3,059 3,027 23 (1) 55 (2) + 32 (1)
Wonsho 431 966 535 (55) 0 (0) 2 535 (124)
Yirgalem town 2588 1,644 26 (2) 970 (37) + 944 (36)
Neighboring zones 216 263 216 263 47
Total 37,333 37,333 6,910 (18.5) 7,004 (18.8) 8,404 (22.6)
A total of 216 cases were cases from the study area, but treated at facilities outside the study area and included in the analysis. A total of 263 cases were
excluded from analysis because they were from other districts, but treated in the study area. Therefore, 37,070 (37,333–263) cases from the study area were
included in the study.
*Number of cases from other districts/number of cases corrected to true address.
**Number of cases of other districts/number of cases reported by BMU.
***Difference between number of cases reported by BMU and number of cases corrected to BMU.
doi:10.1371/journal.pone.0114225.t001
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Ethical Approval
We obtained ethical clearance from the Regional Health Bureau of southern
Ethiopia, in addition to a letter of support from the Sidama Zone Department of
Health, to visit and obtain information from all districts and health facilities. We
coded personal identifiers of cases and kept medical records in a secure place to
help maintain the confidentiality of clinical information of cases prior to analysis.
Results
A total of 37,333 cases were reported as being diagnosed and treated from 2003 to
2012 in the Sidama Zone, although 263 cases from the neighboring region or
zones were excluded from analysis, thus leaving 37,070 (99.3%) cases for analysis.
We identified differences between cases reported by BMU and corrected to the
cases’ addresses (Table 1). A total of 6,910 (18.5%) cases were reported by other
BMUs, which contributed to under reporting, while 7,004 (18.8%) cases were
reported from other districts by the BMUs, which contributed to over reporting.
Facilities in urban areas reported a large proportion of cases from neighboring
rural areas (Table 1).
Of the 37,070 cases, 16,867 (45.5%) were women and 20,193 (54.5%) were
men, yielding a male to female ratio of 1.2:1. The mean age (SD) for all cases was
29 (15) years, (male530 (SD 16) and females527 (SD 13) years). Most of the
cases, a total of 22,545 (61%), were PTB+, 7,989 (22%) were PTB- and 6,464
(17%) were EPTB. A total of 31,912 (86%) cases were from rural areas, whereas
5,158 (14%) were from urban areas. Lastly, 95% (35,314 cases) were new and 5%
(1641) were retreatment cases (Table 2).
Trends in Case Notification Rates
The case notification for all forms of TB steadily increased between 2003–2012
(Figure 1). PTB+ CNR declined from 55 per 105 people in 2003 to 51 per 105
people in 2006 (X2trend, P50.004), while increasing from 58 (95% CI 55.8–61.3)
per 105 people in 2007 to 111 (95% CI 107.4–114.4) in 2012. The case notification
of PTB+ in rural settings declined to 46 per 105 people in 2006 (X2trend, P50.002),
and increased to 110 (95% CI; 106.3–113.5) in 2012. In 2011, the CNR of PTB+
doubled for men and women compared to what it was in 2003 (Table 3). The
disparity between men and women in CNR declined from 16 per 105 people in
2003 to 8 per 105 people in 2012, while the male to female (M: F) ratio declined
from 1.4:1 to 1.1:1. Likewise, the CNR of PTB+ in the 45 year and above age
groups rose by nearly fourfold (Table 3).
Trends in Treatment Outcome
Over a period of 10 years, the treatment outcome under DOTS improved among
all forms, and PTB+ cases cured under DOTS decreased from 68% in 2003 to 53%
in 2008 (X2trend, P,0.001) and increased to 89% (95% CI 87–89.1) in 2012.
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Moreover, cases of all forms of TB lost-to-follow up declined from 12% to 1% in
2012 (X2trend, P,0.001) (Table 4).
The proportion of cases who died during treatment declined from 11% to 3%
for PTB- (X2trend, P,0.001), and from 5% to 2% for PTB+ (X2trend, P,0.001)
Table 3. Trends of smear positive TB case notification rate per 105 people in the Sidama Zone, 2003–2012.
Characteristics Year of treatment
2003 2004 2005 2006 2007 2008 2009 2010 2011 2012
Total PTB+ Cases 1,358 1,586 1,574 1,434 1,734 2,502 2,286 2,156 4,056 3,851
CNRs 55 62 58 51 58 82 73 66 122 111
Residence
Urban 121 191 138 141 128 155 173 136 162 126
Rural 52 54 54 46 55 78 68 63 121 110
Sex
Male 63 68 63 56 63 87 82 74 125 118
Female 47 55 54 46 54 76 64 58 118 110
Age category
0–14 11 12 11 10 10 14 12 11 22 16
15–24 106 110 105 90 106 136 132 120 189 159
25–34 132 145 142 117 136 198 164 154 280 254
35–44 79 101 92 76 101 131 119 96 218 225
45–54 72 105 88 78 78 150 140 121 274 280
55–64 70 76 73 67 77 144 122 113 221 225
65+ 47 49 42 51 48 70 51 77 124 135
doi:10.1371/journal.pone.0114225.t003
Figure 1. Trends of TB case notification rates per 105 people by year and by TB category in the Sidama Zone, 2003–2012.
doi:10.1371/journal.pone.0114225.g001
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Table 4. Trends of treatment outcome among tuberculosis cases in the Sidama Zone, 2003–2012.
Treatment
outcome
2003 N
(%)
2004 N
(%)
2005 N
(%)
2006 N
(%)
2007 N
(%)
2008 N
(%)
2009 N
(%)
2010 N
(%)
2011 N
(%)
2012 N
(%)
Total N
(%)
New cases
PTB+
Completed 209 (16) 418 (26) 384 (26) 422 (31) 499 (30) 603 (26) 621 (29) 493 (25) 299 (8) 142 (4) 4,090 (19)
Cured 891 (68) 825 (54) 771 (51) 625 (46) 859 (52) 1,231 (53) 960 (45) 896 (45) 3,231 (84) 3,241 (89) 13,530
(64)
Lost-to-follow
up
106 (8) 140 (9) 97 (7) 149 (11) 182 (11) 326 (14) 272 (13) 355 (18) 123 (3) 65 (1.4) 1,802 (9)
Died 69 (5.3) 52 (3.4) 40 (3) 46 (3.4) 52 (3) 50 (2) 62 (3) 42 (2) 85 (2) 72 (2) 570 (3)
Failure 4 (0.3) 1 (0.1) 1 (0.1) 0 4 (0.2) 17 (0.7) 12 (0.6) 4 (0.2) 8 (0.2) 10 (0.3) 61 (0.3)
Not evaluated* 24 (2) 83 (6) 210 (14) 122 (9) 68 (4) 112 (5) 190 (9) 197 (10) 111 (3) 125 (3.4) 1,242 (6)
PTB-
Completed 367 (70) 362 (71) 376 (72) 417 (78) 659 (82) 614 (78) 445 (73) 379 (64) 683 (90) 1,850 (93) 6,152 (81)
Lost-to-follow
up
78 (15) 64 (13) 54 (10) 63 (12) 83 (10) 96 (12) 92 (15) 131 (22) 27 (4) 16 (1) 704 (9.2)
Died 59 (11) 49 (10) 32 (6) 31 (6) 38 (5) 26 (3) 20 (3) 23 (4) 29 (4) 54 (3) 361 (5)
Failure 0 0 1 (0.2) 1 (0.2) 0 2 (0.3) 1 (0.2) 2 (0.3) 0 0 7 (0.1)
Not evaluated* 17 (3) 37 (7) 63 (12) 23 (4) 25 (3) 46 (6) 51 (8) 63 (11) 23 (3) 62 (3) 410 (5)
EPTB
Completed 324 (76) 453 (80) 512 (82) 420 (81) 593 (83) 653 (83) 430 (77) 364 (75) 709 (92) 796 (91) 5,254 (83)
Lost-to-follow
up
78 (18) 65 (12) 48 (8) 60 (12) 74 (10) 93 (12) 74 (13) 67 (14) 23 (3) 11 (1) 593 (9.4)
Died 19 (4) 13 (2) 14 (2) 16 (3) 26 (4) 14 (2) 15 (3) 20 (4) 21 (3) 14 (2) 172 (3)
Not Evaluated* 6 (1.4) 32 (6) 51 (8) 23 (4) 19 (3) 26 (3) 38 (7) 37 (8) 20 (3) 58 (7) 310 (5)
Others 0 1 (0.2) 0 0 1 (0.1) 1 (0.1) 4 (0.7) 0 0 0 7 (0.1)
All new TB
cases
Cured +
Completed
1,791 (80) 2,059 (79) 2,043 (77) 1,888 (78) 2,611 (82) 3,104 (79) 2,461 (75) 2,135 (69) 4,922 (91) 6,029 (92) 29,043
(82)
Lost-to-follow
up
262 (12) 269 (10) 199 (8) 275 (11) 340 (11) 517 (13) 440 (13) 554 (18) 173 (3) 79 (1) 3,108 (9)
Died 148 (7) 114 (4.4) 86 (3) 94 (4) 116 (4) 90 (2) 97 (3) 85 (3) 135 (3) 140 (2) 1,105 (3)
Treatment fail-
ure
4 (0.2) 2 (0.1) 2 (0.1) 1 (0) 5 (0.2) 21 (0.5) 17 (0.5) 6 (0.2) 8 (0.1) 10 (0.2) 76 (0.2)
Not evaluated* 47 (2) 155 (6) 324 (12) 168 (7) 113 (4) 186 (5) 279 (9) 297 (10) 154 (3) 245 (4) 1,968
(5.6)
Total 2,252 2,599 2,654 2,426 3,185 3,918 3,294 3,077 5,392 6,503 35,300
Retreatment
cases
Completed 34 (39) 38 (40) 33 (41) 49 (52) 48 (45) 65 (37) 66 (35) 78 (35) 53 (21) 146 (43) 610 (37)
Cured 30 (35) 24 (30) 21 (22) 21 (22) 28 (26) 64 (36) 56 (30) 76 (34) 163 (66) 150 (44) 647 (39)
Lost-to-follow
up
7 (8) 7 (7) 5 (6) 11 (12) 15 (14) 30 (17) 30 (16) 30 (14) 8 (3) 12 (4) 155 (9)
Died 11 (13) 9 (7) 6 (8) 6 (6) 9 (8) 4 (2) 14 (8) 12 (5) 10 (4) 11 (3) 92 (6)
Failure 1 (1) 1 (1) 1 (1.3) 1 (1) 0 4 (2.3) 1 (0.5) 4 (2) 2 (0.8) 1 (0.3) 16 (1)
Not evaluated 4 (5) 4 (4) 11 (14) 7 (7) 7 (7) 9 (5) 20 (11) 23 (10) 12 (5) 23 (7) 119 (7)
Total 87 94 80 95 107 176 187 223 248 343 1,640
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(Figure 2 and Table 4). More deaths occurred in PTB- than PTB+ cases (AOR
1.65; 95% CI: 1.44–1.90), and similarly, cases in the age groups above 34 years and
children had more deaths compared with the 15-24-year-old age group (Table 5).
Additionally, patients older than 65 years were almost four times more likely to
die during treatment than young adults (AOR 3.86; CI 95%: 2.94–5.10) (Table 5).
Cases from rural areas had a higher treatment success (AOR 1.11; CI 95%:
1.03–1.2) than cases from urban areas, whereas the treatment success was less for
PTB- cases (AOR 0.86; CI 95%: 0.80–0.92) and more for EPTB cases (AOR 1.10;
CI 95%: 1.02–1.19) compared with PTB+ cases (Table 5). Significant differences
were also observed in treatment success, loss-to-follow up and mortality between
years of treatment (Table 5), and both men (AOR 1.15; CI 95%: 1.06–1.24) and
smear-negative cases also had higher loss-to-follow up rates (AOR 1.14; CI 95%:
1.03–1.25).
Discussion
We found an increased case notification rate, improved treatment success and a
decline in poor treatment outcomes over the past 10 years. However, we noted
*Not evaluated5Transferred out cases + Cases for whom treatment outcome was unknown.
Fourteen new and 1 retreatment cases were excluded because the year of treatment was not mentioned.
One case recorded as treatment failure had no TB classification.
doi:10.1371/journal.pone.0114225.t004
Figure 2. Trends of mortality among TB cases during treatment in the Sidama Zone, 2003–2012.
doi:10.1371/journal.pone.0114225.g002
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varying CNRs and treatment outcomes during the study period, and we also
found less urban-rural and gender discrepancies in case notification rates.
Globally, gender inequalities have been reported in TB case notification [2],
with the male to female ratios ranging from 1.5:1 -2.2:1[5, 27], but in contrast,
lower male to female ratios were reported from Asia [1, 28]. The male to female
ratios in our data were lower than reports from other studies. The decline in male
to female ratio and a narrowing gender disparity gap in our data could be
attributed to an improved access to TB control services [15] and active case
finding interventions [15, 16], while gender differences in case notification could
be due to access to health services [29], biological-, socio-economic- and cultural
Table 5. Various factors associated with treatment success, loss-to-follow up and mortality among 35,314 new tuberculosis cases in the Sidama Zone, 2003-
2012.
(n535314) Treatment success Lost-to-follow up Mortality
Characteristics %
Adjusted OR
(95% CI) P-value %
Adjusted OR
(95% CI) P-value %
Adjusted OR
(95% CI) P-value
Sex
Female 83.8 1.00 8.0 1.00 2.9 1.00
Male 81 0.86 (0.81–0.91) ,0.001 9.4 1.15 (1.06–1.24) 0.001 3.4 1.07 (0.94–1.21) 0.298
Age group
0–14 81.3 0.86 (0.78–0.95) 0.002 10.2 1.2 (1.09–1.40) 0.001 3 1.4 (1.09.6–1.70) 0.007
15–24 83.1 1.00 8.4 1.00 2.1 1.00
25–34 82.6 0.92 (0.85–0.99) 0.031 8.6 1.1 (0.97–1.90) 0.163 2.8 1.37 (1.14–1.65) 0. 001
35–44 82.7 0.88 (0.8–0.97) 0.009 8.2 1.08 (0.95–1.23) 0.264 3.6 1.78 (1.46–2.21) ,0.001
45–54 82.9 0.87 (0.78–0.97) 0.010 7.8 1.06 (0.91–1.24) 0.431 4.3 2.22 (1.80–2.80) ,0.001
55–64 79.3 0.71 (0.61–0.81) ,0.001 9.8 1.3 (1.1–1.6) 0.003 6.1 3.1 (2.39–3.96) ,0.001
65+ 78.6 0.72 (0.60–0.84) ,0.001 8.7 1.11 (0.87–1.4) 0.399 8 3.86 (2.94–5.10) ,0.001
Residence
Urban 79.6 1.00 9.1 1.00 3.5 1.00
Rural 82.7 1.11 (1.03–1.2) 0.010 8.8 1.1 (.97–1.21) 0.143 3.1 0.98 (.82–1.15) 0.703
TB classification
PTB+ 82.7 1.00 8.5 1.00 2.7 1.00
PTB- 80.5 0.86 (0.80–0.92) ,0.001 9.2 1.14 (1.03–1.25) 0.009 4.7 1.65 (1.44–1.90) ,0.001
EPTB 82.9 1.1 (1.02–1.19) 0.016 9.4 1.03 (0.94–1.14) 0.525 2.7 0.95 (0.79–1.13) 0.532
Year of treatment
2003 79.5 1.00 11.6 1.00 6.6 1.00
2004 79.2 0.98 (.85–1.12) 0.74 10.4 0.89 (0.74–1.07) 0.20 4.4 0.66 (0.51–0.85) 0.001
2005 77.0 0.85 (0.74–0.97) 0.017 7.5 0.62 (0.51–0.75) ,0.001 3.2 0.48 (0.37–0.63) ,0.001
2006 77.8 0.91 (0.79–1.05) 0.20 11.3 0.96 (0.80–1.15) 0.656 3.9 0.50 (0.42–0.72) ,0.001
2007 82.0 1.18 (1.03–1.35) 0.02 10.7 0.88 (0.74–1.05) 0.253 3.6 0.53 (0.41–0.68) ,0.001
2008 79.2 0.99 (0.87–1.13) 0.912 13.2 1.14 (0.97–1.34) 0.112 2.3 0.33 (0.26–0.44) ,0.001
2009 74.7 0.75 (0.66–.85) ,0.001 13.4 1.19 (1.01–1.40) 0.042 2.9 0.44 (0.33–0.57) ,0.001
2010 69.4 0.58 (0.51–0.66) ,0.001 18.0 1.68 (1.43–1.97) ,0.001 2.8 0.40 (0.30–0.53) ,0.001
2011 91.3 2.6 (2.3–3.05) ,0.001 3.2 0.26 (0.21–0.31) ,0.001 2.5 0.36 (0.29–0.46) ,0.001
2012 92.7 3.3 (2.9–3.8) ,0.001 1.2 0.09 (0.07–0.12) ,0.001 2.2 0.26 (0.21–0.34) ,0.001
doi:10.1371/journal.pone.0114225.t005
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factors [27, 30–32], as well as poor knowledge and diagnosis delays [9].
Nonetheless, because active case finding have exhibited similar trends for both
men and women, we believe that access to health services was the primary reason
for improving gender differences.
Furthermore, we found a higher CNR of PTB+ in urban- than in rural settings,
which could be explained by adverse conditions such as poor socioeconomic
status [33, 34], overcrowding [7] and a high prevalence of HIV/AIDS [35].
Previous studies from southern Ethiopia reported higher TB and HIV co-infection
rates (25–30%) in cases from urban settings [36, 37], and the demographic and
health survey of Ethiopia also reported a higher prevalence of HIV in urban- than
in rural settings [38].
We found a steady increase in CNR among younger groups and a more than
twofold increase in older groups. However, no age groups showed a decreasing
trend in CNR over the past decade. In developed countries, the age shift occurred
over a period of years, with TB being common in older age groups due to an aging
population and the changing epidemiology of the disease [39–41]. In developing
and high burden countries, the disease is common among younger age groups
[1, 41]. The increasing trend in CNR in the 65 year olds in our study was
consistent with a study from South Korea, though unlike our finding, the
proportion of notified TB cases in South Korea for those under the age of 65
decreased [39]. This difference could be due to population distribution because
the proportion of notified cases over 65 years in Korea was higher than notified
cases over 65 years in our study, which could also be because of active case finding
interventions in the study area [15, 16]. The increase in CNR among the older age
group in our study indicates TB among the old has been under-diagnosed, while
the observed increase in CNRs during the study period could be attributed to
improved access to- and utilization of TB control services [15, 16]. Hence, the
DOTS services and community-based interventions in the study area have an
improved access to- and use of TB services, as well as a reduced under-diagnosis
of TB among older age groups. Nevertheless, increasing aging is related to
increased risk due to a reduced immunity and co-morbidities such as diabetes,
malignancies and other factors that increase cases [39, 41]. The increased CNR
among older age groups in our study should be interpreted with caution because
studies on age shift in TB occurrence report an age shift after a long study period
usually lasting for decades.
Treatment success was poor in 2008–2010, although a notable improvement
was observed in 2011–2012. This improvement could be due to an improved
access to TB control services, particularly community-based interventions [15],
early diagnosis and treatment of the cases, reduction in lost-to-follow up and a
decline in the mortality of patients while on treatment. Similarly, a remarkable
decline in lost-to-follow up of cases in 2011–2012 could be explained by
community-based interventions, which improved access to- and the use of TB
control services. Other possible reasons for a notable reduction in lost-to-follow
up could be the drop in the proportion of non-evaluated cases compared to
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preceding years, the expansion of TB treatment centers and a regimen change of
the continuation phase to RH, which lasts four months.
In our study, more men were lost-to-follow up than women, with this finding
consistent with other studies [42, 43]. PTB- cases were associated with a higher
loss-to- follow up, which is consistent with a previous study from southern
Ethiopia [44]. Conversely, a study from Nigeria reported a higher loss-to- follow
up among PTB+ cases [42]; this difference could be due to a longer study period, a
larger cohort of TB cases and wider geographic settings in our study.
The proportion of cases who died on treatment declined during the study
period; however, unlike other studies, there were no significant differences in
mortality by gender and urban-rural settings [45]. This could be explained by
improved access to, and utilization of TB control services and an improved
awareness of the disease. The proportion of cases who died on treatment among
the age group of 65 years and above in our data was fourfold compared to
younger adults. This finding was in agreement with the study from southern
Ethiopia, which reported a higher mortality rate among the elderly [44]. This
could be due to an increased risk of co-morbidities and delay in diagnosis and
treatment among older age groups, which could increase adverse treatment
outcomes [41].
The higher proportion of deaths in PTB- cases than PTB+ and EPTB cases in
our data might be due to diagnosis and treatment delays, as well as HIV infection
among PTB- cases. Studies reported more PTB- cases among HIV-infected
individuals [36, 46], while previous studies from southern Ethiopia also reported a
high TB-HIV co-infection, with the rate of HIV infection among PTB- cases being
18–26% [36, 37]. The declining trend in mortality during treatment in our study
may be explained in part by ART services because ART reduces deaths in TB cases
infected with HIV [47]. In recent years, there has been an increase in both ART
centers and the number of patients starting ART in the study area [24].The
number of ART centers in the study area increased from one to 20 during the
study period. More deaths were also observed among retreatment cases, which is
consistent with other reports [48, 49]. Retreatment cases could be drug resistant
TB, repeated infection, a recurrence due to a reduced immunity and other co-
morbidities that could increase the risk of death.
In our study, we found variations in cases notified by BMU in relation to place
of residence, which might mask the real epidemiology of TB in the community.
We noted both over- and underreporting of cases within districts in study area;
the over reporting was mainly observed from urban health facilities, with the
underreporting occurring at neighboring rural areas. This could be attributed to
poor access to health facilities that provide TB services for rural areas in their
catchment since people use the closest health facilities regardless of their actual
address. If health facilities fail to correctly record and report the actual address of
patients, and include or miss cases in the numerator of case notification, it results
in an under- or over reporting of cases. On the other hand, people may bypass the
closer health facility and use health services further away because of patient
preference due to poor service delivery in the nearby health facilities or the
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distribution of health facilities that did not consider the population distribution
and required coverage. This finding is important for the TB control program and
district authorities because the over- or underreporting of cases may conceal a
true burden of the disease, which may lead to flawed conclusions for targeting
interventions and resource allocation. Data aggregation based on the correct
address of cases could help solve the problem of over- or under-reporting. Thus,
improving the recording of the actual patient address and access to TB control
services might solve such discrepancies in actual case notification.
One limitation of our study is that patients with no address could be missed;
however, the percentage of patients with a missed address and information was
too small to affect the results. PTB- and EPTB could also be over- or
underestimated because of poor access to standard diagnosis facilities such as
culture and histopathology. Information about HIV status and treatment was not
available in the registers; consequently, we could not compare the treatment
outcomes based on HIV status and treatment. In addition, our study was not a
population-based survey, so cases occurring in the community may remain
undiagnosed, and a few may remain unregistered. The strengths of our study were
that the study was carried out on a large cohort of TB cases, covering a large
geographic area and both urban and rural settings. Lastly, this is the first study
from Ethiopia that uses patients’ true home addresses to assess the results of a
tuberculosis control program, as previous studies have been based on reports
from BMU that did not consider the actual address of cases.
Conclusions
We have reported that over the past 10 years, TB case notification rates increased,
poor treatment outcomes were reduced, while disparities of the disease burden by
gender and place of residence also declined. Understanding the epidemiology of
TB in such settings is important for resource planning, monitoring and
understanding the burden of the disease in the community. Strategies should
therefore be devised to address higher risk groups for poor treatment outcomes.
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